Go to Previous Versions
of
this Article
2025 Code of Georgia
Title 31 - Health (Chs. 1 — 54)
Chapter 52 - Terminally Ill Patient’s Right to Try Investigational Drugs, Biological Products, and Devices (Arts. 1 — 2)
Article 1 - Right to Try (§§ 31-52-1 — 31-52-10)
Annotations
Notes
Editor’s notes.Ga. L. 2025, p. 455, § 1/SB 72, not codified by the General Assembly, provides: “This Act shall be known and may be cited as the ‘Hope for Georgia Patients Act.’”
Ga. L. 2025, p. 455, § 2/SB 72, effective July 1, 2025, designated the existing provisions of this chapter (Code Sections 31-52-1 through 31-52-10) as Article 1.
Research References & Practice Aids
Hierarchy Notes:O. C. G. A. Title 31
Universal Citation:
O.C.G.A. Title 31, Ch. 52, Art 1
Learn more
This media-neutral citation is based
on the American Association of Law Libraries Universal Citation Guide and is not
necessarily the official citation.
- § 31-52-1. Short title
- § 31-52-2. Legislative findings
- § 31-52-3. Definitions
- § 31-52-4. Eligibility criteria
- § 31-52-5. Written informed consent
- § 31-52-6. Manufacturers permitted to make investigational drugs, biological products, or devices available
- § 31-52-7. Coverage under health benefit plan permitted but not required
- § 31-52-8. Physician immunity from professional sanction
- § 31-52-9. State prohibited from blocking eligible patient access
- § 31-52-10. Statutory construction; immunity from liability
Disclaimer: These codes may not be the most recent version. Georgia may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
